ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Renal dysfunction"

  • 2022 American Transplant Congress

    On the Circuit: Intra-Operative CRRT in Pediatric Liver Transplant Recipients with Acute Kidney Injury

    E. Blanchette1, M. Chandran2, D. Yoeli3, M. Adams3, M. Bock1

    1Pediatric Nephrology, University of Colorado, Aurora, CO, 2Transplant Pharmacy, University of North Carolina, Raleigh, NC, 3Transplant Surgery, University of Colorado, Aurora, CO

    *Purpose: Acute renal failure is common in pediatric patients undergoing liver transplantation (LT), with an incidence of 17-55%. Fluid, metabolic and acid-base aberrancies are often…
  • 2022 American Transplant Congress

    Daratumumab Therapy Achieves Dialysis Independence in Kidney Transplant Recipients with Resistant Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits

    P. Yenebere, R. Daloul

    The Ohio State University, Columbus, OH

    *Purpose: Proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID) is a unique cause for monoclonal gammopathy of renal significance with overall poor prognosis. Patients are frequently…
  • 2022 American Transplant Congress

    Meta-Analysis of the Chronic Exposure to Calcineurin Inhibitors and the Risk for Chronic and End-Stage Kidney Disease in Non-Renal Solid Organ Transplant Recipients

    A. Alvarez Elias1, M. Riedl1, D. Stewart2, A. Ruco3, P. Bobos3, S. Maharaj4, V. Shah5, E. Uleryk6, C. Teoh1, R. Parekh1

    1Hospital for Sick Children, Toronto, ON, Canada, 2Royal Hospital for Children, Glasgow, United Kingdom, 3St. Michael’s Hospital, Toronto, ON, Canada, 4University of Toronto, Toronto, ON, Canada, 5Mount Sinai Hospital, Toronto, ON, Canada, 6E. M. Uleryk Consulting, Toronto, ON, Canada

    *Purpose: Calcineurin inhibitors (CNI) are standard of care immunosuppressants among all solid organ transplant (SOT) recipients, and the most common side effect is nephrotoxicity. There…
  • 2022 American Transplant Congress

    Re-Examining the Optimal Threshold for Donor Derived Cell Free DNA in Renal Allograft Rejection

    H. Murad1, M. Merzkani1, M. Ji1, S. Chang1, A. Malone1, R. Delos Santos1, T. Alhamad2

    1Washington University in St. Louis, St Louis, MO, 2Washington University in St. Louis, Saint Louis, MO

    *Purpose: Due to the invasive nature and potential complications of allograft biopsies, there is an important role for surrogate biomarkers to help identify rejection early,…
  • 2021 American Transplant Congress

    Chances of Renal Recovery in Liver Only Transplant Recipients Who Were Eligible for Simultaneous Liver-Kidney Transplant

    J. Cui1, A. Spann2, A. Shingina2, H. M. Schaefer3, J. C. Slaughter4, S. Alexopoulos5, M. Izzy2

    1Internal Medicine, Vanderbilt University Medical Center, Nashville, TN, 2Gastroenterology, Hepatology, and Nutrition, Vanderbilt University Medical Center, Nashville, TN, 3Nephrology, Vanderbilt University Medical Center, Nashville, TN, 4Biostatistics, Vanderbilt University Medical Center, Nashville, TN, 5Hepatobiliary Surgery and Liver Transplantation, Vanderbilt University Medical Center, Nashville, TN

    *Purpose: Progressive decline in renal function is common among patients with end-stage liver disease. Liver transplant (LT) candidates can often develop severely impaired renal function…
  • 2021 American Transplant Congress

    Temporal Changes in Renal Function Predict Waitlist Death or Deterioration in Pediatric Liver Transplantation

    N. Thalji, L. Thalji, S. Ibrahim, T. Diwan, P. Kamath, J. Heimbach

    Mayo Clinic Rochester, Minnesota, Rochester, MN

    *Purpose: Renal dysfunction at the time of listing predicts inferior waitlist outcomes in pediatric liver transplant candidates, independent of the Pediatric End-Stage Liver Disease (PELD)…
  • 2021 American Transplant Congress

    Therapeutic Enoxaparin Dosing in Lung Transplant Recipients

    S. Finder, M. Morrison, K. B. Harrison, S. A. Heeney

    Vanderbilt University Medical Center, Nashville, TN

    *Purpose: Enoxaparin 1 mg/kg subcutaneously every 12 hours for therapeutic anticoagulation is known to increase rates of supratherapeutic anti-Xa levels in lung transplant recipients (LTRs).…
  • 2021 American Transplant Congress

    Assessing the Impact of Acute Major Adverse Kidney Events on Clinical Outcomes in Heart Transplant Recipients

    J. E. Kelly1, C. Perez1, D. Taber1, R. J. Tedford2, B. McMahon2, S. Alzaidi1, H. B. Meadows1

    1Pharmacy, MUSC Health, Charleston, SC, 2Medicine, MUSC Health, Charleston, SC

    *Purpose: The purpose of this study was to elucidate contributors to the Major Adverse Kidney Events at 30 days (MAKE-30) outcome in heart transplant recipients…
  • 2021 American Transplant Congress

    Pre Transplant Estimated Glomerular Filtration Rate and Other Predictors of Mortality and End Stage Kidney Disease After Lung Transplantation

    A. Kumar1, L. N. Bonnell2, C. Thomas3

    1Internal Medicine, University of Vermont, Burlington, VT, 2Department of General Internal Medicine Research, University of Vermont, Burlington, VT, 3Internal Medicine, University of Iowa, Iowa City, IA

    *Purpose: Lung transplantation is an established treatment for end stage lung disease and as survival has improved, chronic kidney disease (CKD) has become a common…
  • 2021 American Transplant Congress

    The Trifecta Study: Calibrating Circulating Donor-Derived Cell-Free DNA at the Time of Indication Biopsies Against the Molecular Phenotype of the Biopsy Reveals a Prominent Association with NK Cell Genes

    P. Halloran1, Z. Demko2, A. Prewett2, J. Reeve1, P. Billings2

    1Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada, 2Natera Inc., San Carlos, CA

    *Purpose: The international, multicenter, prospective Trifecta study was designed to calibrate dd-cfDNA% measurements in blood at the time of indication biopsy against the molecular characteristics…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 17
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences